NAYA - NAYA Biosciences, Inc.
1.73
-0.200 -11.561%
Share volume: 203,275
Last Updated: 04-09-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$1.93
-0.20
-0.10%
Fundamental analysis
15%
Profitability
0%
Dept financing
25%
Liquidity
6%
Performance
30%
Performance
5 Days
-17.48%
1 Month
474.75%
3 Months
112.69%
6 Months
105.95%
1 Year
105.95%
2 Year
105.95%
Key data
Stock price
$1.73
DAY RANGE
$1.38 - $2.00
52 WEEK RANGE
$0.19 - $2.75
52 WEEK CHANGE
$105.95
DIVIDEND
$0.00
EX-DIVIDEND DATE
03-18-2025
NEXT EARNINGS DATE
05-14-2025
Company detail
CEO: Steven M. Shum
Region: US
Website: www.nayabiosciences.com
Employees: 10
IPO year: 2008
Issue type:
Market: NASDAQ
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: www.nayabiosciences.com
Employees: 10
IPO year: 2008
Issue type:
Market: NASDAQ
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
NAYA Biosciences (NASDAQ: NAYA) is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility.
Recent news
NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025
SARASOTA, Fla. and MIAMI, March 13, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women’s health, and a leading provider of in vitro fertilization (IVF) and in vivo Intravaginal Culture (“IVC”) fertility treatments, announced today that it will effect a 1-for-12 reverse split of its issued and outstanding and authorized common stock effective
Read more